PublisherBMJ Publishing Group
MetadataShow full item record
DescriptionAuthor discusses paroxetine, an antidepressant manufactured by GlaxoSmithKline, its use in adolescents, the controversy over Study 329, and the company's continued reticence to share all of its clinical trial data.
CitationDoshi, P. (2013). Putting GlaxoSmithKline to the test over paroxetine. BMJ, 347. DOI: 10.1136/bmj.f6754
Restoring Invisible and Abandoned Trials
Access to Information
Clinical Trials as Topic
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/6614